Litcius/Paper detail

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer

Ding Ma, Lei-Jie Dai, Xiangrong Wu, Chenglin Liu, Shen Zhao, Hang Zhang, Li Chen, Yi Xiao, Min Li, Yi-Zhi Zhao, Lin Yang, Tong Zhou, Junjie Li, Wentao Yang, Yizhou Jiang, Zhi‐Ming Shao

2025Cancer Cell44 citationsDOI

Topics & Concepts

Antibody-drug conjugateBreast cancerConjugateAntibodyDrugMedicineCancer researchNeoadjuvant therapyOncologyCancerPharmacologyInternal medicineImmunologyMonoclonal antibodyMathematical analysisMathematicsHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchAdvanced Biosensing Techniques and Applications
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer | Litcius